- Abstract:
-
In March of 2018, the National Kidney Foundation, in collaboration with the US Food and Drug Administration and the European Medicines Agency, sponsored a workshop in which surrogate endpoints other than currently established event‐time endpoints for clinical trials in chronic kidney disease (CKD) were presented and discussed. One such endpoint is a slope‐based parameter describing the rate of decline in the estimated glomerular filtration rate (eGFR) over time. There are a number of challeng...
Expand abstract - Publication status:
- Published
- Peer review status:
- Peer reviewed
- Publisher:
- Wiley Publisher's website
- Journal:
- Statistics in Medicine Journal website
- Volume:
- 38
- Issue:
- 22
- Pages:
- 4218-4239
- Publication date:
- 2019-07-23
- Acceptance date:
- 2019-05-29
- DOI:
- EISSN:
-
1097-0258
- ISSN:
-
0277-6715
- Pubs id:
-
pubs:1035881
- UUID:
-
uuid:f23e1b05-6d8e-4634-9eb2-a5775f2dc619
- Source identifiers:
-
1035881
- Local pid:
- pubs:1035881
- Language:
- English
- Keywords:
- Copyright holder:
- John Wiley & Sons, Ltd.
- Copyright date:
- 2019
- Rights statement:
- © 2019 John Wiley & Sons, Ltd.
- Notes:
- This is the accepted manuscript version of the article. The publisher's version is available online
Journal article
Mixed‐effects models for slope‐based endpoints in clinical trials of chronic kidney disease
Actions
Authors
Bibliographic Details
Item Description
Terms of use
Metrics
Altmetrics
Dimensions
If you are the owner of this record, you can report an update to it here: Report update to this record